These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31172218)

  • 1. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
    Muri L; Leppert D; Grandgirard D; Leib SL
    Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and ADAMs in stroke.
    Montaner J; Ramiro L; Simats A; Hernández-Guillamon M; Delgado P; Bustamante A; Rosell A
    Cell Mol Life Sci; 2019 Aug; 76(16):3117-3140. PubMed ID: 31165904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple roles of metalloproteinases in neurological disorders.
    Yang Y; Hill JW; Rosenberg GA
    Prog Mol Biol Transl Sci; 2011; 99():241-63. PubMed ID: 21238938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in the CNS: interferons get nervous.
    Chopra S; Overall CM; Dufour A
    Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
    Gasche Y; Soccal PM; Kanemitsu M; Copin JC
    Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of matrix metalloproteinases in regulating neuronal disorder.
    Mukherjee A; Swarnakar S
    Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in neuroinflammation.
    Rosenberg GA
    Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
    Rosenberg GA
    Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
    Candelario-Jalil E; Yang Y; Rosenberg GA
    Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.
    Opdenakker G; Abu El-Asrar A
    Cell Mol Life Sci; 2019 Aug; 76(16):3157-3166. PubMed ID: 31183508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
    Lindberg RL; De Groot CJ; Montagne L; Freitag P; van der Valk P; Kappos L; Leppert D
    Brain; 2001 Sep; 124(Pt 9):1743-53. PubMed ID: 11522577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
    Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
    Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteinases and their inhibitors in neurological disease.
    Lopez-Navarro ER; Gutierrez J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):27-38. PubMed ID: 34851449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.
    Li Y; Wang W; Li L; Khalil RA
    Life Sci; 2020 Jul; 253():117659. PubMed ID: 32283055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.
    Okazaki I; Nabeshima K
    Anticancer Agents Med Chem; 2012 Sep; 12(7):688-706. PubMed ID: 22292751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
    Sharma D; Singh NK
    Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.